𝔖 Bobbio Scriptorium

✦ LIBER ✦

A Phase I Study Of Clofarabine Plus High Dose Melphalan As A Conditioning Regimen For Allogeneic Transplantation

✍ Scribed by M.H. Kirschbaum; A.S. Stein; R. Nakamura; N. Auayporn; L. Popplewell; M. Delioukina; R. Chen; D. Snyder; J. Conrad; P. Frankel; S.J. Forman

Book ID: 116281566
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 58 KB
Volume: 16
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2009.12.367

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase I Study in Adults of Clofarabine

A Phase I Study in Adults of Clofarabine Combined with High-Dose Melphalan as Reduced-Intensity Conditioning for Allogeneic Transplantation

✍ Mark H. Kirschbaum; Anthony S. Stein; Leslie Popplewell; Maria Delioukina; Rober 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 295 KB

Phase I-II Study of Clofarabine-Melphala

Phase I-II Study of Clofarabine-Melphalan-Alemtuzumab Conditioning for Allogeneic Hematopoietic Cell Transplantation

✍ Koen van Besien; Wendy Stock; Elizabeth Rich; Olatoyosi Odenike; Lucy A. Godley; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 305 KB

A Phase 2 Study of Bortezomib Plus High-

A Phase 2 Study of Bortezomib Plus High-Dose Melphalan Conditioning for Autologous Hematopoietic Cell Transplantation in Multiple Myeloma

✍ T. Nishihori; J.L. Ochoa-Bayona; J. Pidala; K. Shain; R. Baz; C.M. Simonelli; D. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Phase I-II Study of Clofarabine-Melphala

Phase I-II Study of Clofarabine-Melphalan-Alemtuzumab Conditioning for Allogeneic Hematopoietic Cell Transplantation (HCT) in Patients with Advanced Hematologic Malignancies: Unexpected Renal Toxicity

✍ K. van Besien; J. Kline; L. Godley; R.A. Larson; O. Odenike; E.S. Rich; W. Stock 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 46 KB

A phase I study of 153Sm-EDTMP with fixe

A phase I study of 153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma

✍ Dispenzieri, A; Wiseman, G A; Lacy, M Q; Litzow, M R; Anderson, P M; Gastineau, 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 171 KB

Bortezomib and High-Dose Melphalan as a

Bortezomib and High-Dose Melphalan as a Novel Conditioning Regimen for Patients With Poems Syndrome Undergoing Autologous Peripheral Blood Stem Cell Transplantation

✍ X. Tang; X. Shi; X. Hu; S. Xue; H. Qiu; Y. Han; L. Yan; H. Zhou; Y. Liu; B. Gu; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 58 KB